AXIOS Stent and Electrocautery Enhanced Delivery System
A Endoscopic Intervention Devices Related Image
(Not Necessarily related to the device)
Description:
AXIOS Stent and Electrocautery Enhanced Delivery System by Boston Scientific Corporation
The AXIOS Stent and Electrocautery Enhanced Delivery System is a pioneering medical device designed by Boston Scientific Corporation. This system is primarily utilized for the management of symptomatic pancreatic pseudocysts and certain types of walled-off pancreatic necrosis (WOPN). It combines the benefits of a fully covered, self-expanding metal stent and an electrocautery-enhanced delivery system, making this device pivotal in the field of endoscopic interventions.
The primary function of AXIOS™ Stent is to create a secure, patent connection between the target tissue and the gastrointestinal tract, aiding in effective drainage and subsequent healing of the tissue. The electrocautery-enhanced delivery system facilitates the direct and efficient placement of the stent, reducing the potential of complications, thereby providing a safer procedural environment.
This system provides several key benefits over traditional methods. These include a reduction in the procedural steps, utilization time, and X-ray exposure. The sturdy design of the device enhances stability during placement, ensuring a controlled and exact deployment. This not only mitigates potential risks during the procedure but also improves the overall therapeutic effectiveness of pancreatic pseudocysts and WOPN management.
In summary, the AXIOS Stent and Electrocautery Enhanced Delivery System offers a seamless fusion of efficacy, safety, and precision, redefining the standards for endoscopic interventions.
Primary Use:
AXIOS Stent and Electrocautery Enhanced Delivery System: Primary Use
The AXIOS Stent and Electrocautery Enhanced Delivery System represents a major advancement in endoscopy technology. It is a revolutionary tool in the field of gastroenterology, particularly in treating pancreatic fluid collections (PFCs) as well as several other related conditions.
Therapeutic Endoscopy and The Role of AXIOS
Compared to traditional endoscopy methods, the AXIOS System provides a unique and advanced endoscopic treatment solution. Its primary use can be observed in the area of therapeutic endoscopy, where it streamlines the entire procedure through a single-step, over-the-wire placement of a fully covered, self-expandable metal stent for transgastric or transduodenal drainage of symptomatic pancreatic pseudocysts and walled-off necrosis (WON).
Technique Enhancement with Electrocautery Feature
One of the key features of the AXIOS Stent that sets it apart is its high-quality electrocautery component. This tool enables the simultaneous use of an electrocautery enhanced delivery system, which allows physicians to access and drain these collections swiftly and safely, minimizing the procedure time and potentially reducing the risk of complications.
Outlining the Benefits
In essence, the AXIOS Stent and Electrocautery Enhanced Delivery System provides an innovative, effective, and minimally invasive option designed to improve patient outcomes. This technology, combining a stent with an electrocautery device, simplifies the traditionally multi-step process involved in the drainage of PFCs.
This unique technology is a valuable addition to any endoscopy suite and an essential resource for clinicians seeking to provide cutting-edge, patient-oriented care in the field of gastrointestinal diseases.
How It Works:
AXIOS Stent and Electrocautery Enhanced Delivery System
The AXIOS™ Stent and Electrocautery Enhanced Delivery System signifies a splendid advancement in the complex arena of pancreatic fluid collections (PFCs) treatment.
This unique system incorporates dual therapeutic solutions: a fully covered, therapeutic, gastrometry stent, and an electrocautery-enabled access system. The harmonious integration of these elements furnishes a streamline, simple, single-step intervention to transenteric drainage of PFCs.
Functional Mechanism
The AXIOS System is used to perform endoscopic ultrasound (EUS) guided transenteric drainage procedures. Upon identifying the fluid collection, the AXIOS System matriculates through the gastrointestinal wall using cautery. Once successful access to the PFC is achieved, the stent delivery system is advanced over the guidewire, deploying the proximal flange of the stent into the PFC. Consequently, the distal flange is unfurled within the gastrointestinal lumen, ensuring a secure and patent fluid communication path.
The substantial technological leap is evident in the combination of stent delivery and electrocautery capability. This reduces procedural steps and imparts better control to the endoscopist during the entire intervention.
Key Advancements
1. Streamlined procedure: this system delivers the stent by integrating a cautery-enabled access device that collapses into multiple essential steps into one, thereby simplifying therapeutic EUS.
2. Reduced procedure risks: the stent is designed with large flanges at both ends, greatly mitigating stent migration and ensuring secure placement.
3. Patient centric intervention: as it is fully covered, alleviating potential leakage and enhancing patient safety post-procedure.
AXIOS empowers endoscopists to treat PFCs endoscopically, thus reducing the need for more invasive surgical interventions, while facilitating quicker, safer patient recovery.
It is an invaluable tool for endoscopic intervention, reflecting the strides in progression that have been made in the treatment of pancreatic fluid collections.
Manufacturer:
Boston Scientific Corporation
Status: In Stock
Are you the owner or manufacturer of this device? Need to update anything on this page or get in touch with us? Click here.